Pharmaceuticals, Biotechnology and Life Sciences
$1.3 Million in Operating Expense Reductions Achieved– Operating Loss Improves 19% Year-Over-YearResilient Portfolio Performance with International Sales Despite Global Economic…
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq:…
Aggregated presentation by day and by market Statement of transactions in own shares from August 18th to August 22nd 2025…
Financial Results and Operational Update for the Full Year Ended June 30, 2025NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) —…
WOODCLIFF LAKE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced…
All dollar amounts reflected in Canadian dollars unless otherwise statedVANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics…
EUGENE, Ore., Aug. 28, 2025 (GLOBE NEWSWIRE) — Cascade Prodrug, Inc. (“Cascade”), a biotechnology company focused on advancing novel Hypoxia…
WINNIPEG, Manitoba, Aug. 28, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announced…
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology…
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially…